APOE and Alzheimer disease: Rapamycin treatment in APOE transgenic mice also attenuates neuroinflammation by improving cerebral blood flow through activation of endothelial nitric oxide synthetase [71], thereby helping to maintain integrity of the BBB otherwise compromised in AD [72].